Literature DB >> 30344695

Mutation analysis of the ABCC2 gene in Chinese patients with Dubin-Johnson syndrome.

Lina Wu1, Wei Zhang1, Siyu Jia1, Xinyan Zhao1, Donghu Zhou1, Anjian Xu1, Weijia Duan1, Zhen Wu1, Hai Li2, Sujun Zheng3, Yuemin Nan4, Jidong Jia1, Jian Huang1, Xiaojuan Ou1.   

Abstract

Dubin-Johnson syndrome (DJS) is a rare, autosomal recessive disorder characterized by predominantly conjugated hyperbilirubinemia, caused by a mutation in the adenosine triphosphate-binding cassette subfamily C member 2 (ABCC2) gene coding the multidrug resistance-associated protein 2 (MRP2) protein. ABCC2 mutations have been identified in patients with DJS worldwide; however, the mutation pattern of ABCC2 in China is not well studied. In the present study, the mutation pattern of the ABCC2 gene in Chinese patients with DJS was investigated. A total of 7 clinically confirmed patients with DJS were enrolled, and mutation analysis of the ABCC2 gene was performed by Sanger sequencing of genomic DNA extracted from whole blood. All 32 exons and the adjacent splice junction areas were sequenced. All cases were identified to harbor at least one non-synonymous variant in the ABCC2 gene, including three known mutations in 3 cases and three novel variants (p.G693R, p.G808V and p.E647X) in the other 4 cases, with the known p.R393W and the novel p.G693R and p.E647X variants identified in 2 of the 7 cases (28.6%), respectively. All the identified mutations were heterozygous, and 1 case presented with a compound heterozygous mutation, namely p.G693R/p.G808V, while the other cases carried only one single mutation. The loss of membrane expression of MRP2 caused by the novel nonsense variant, p.E647X, was confirmed by immunohistochemical analysis of liver biopsy. The present study provided the first report on the mutation patterns of the ABCC2 gene in Chinese patients with DJS, and the clinical association of these mutations with the syndrome.

Entities:  

Keywords:  Dubin-Johnson syndrome; adenosine triphosphate-binding cassette subfamily C member 2; multidrug resistance-associated protein 2; mutation

Year:  2018        PMID: 30344695      PMCID: PMC6176208          DOI: 10.3892/etm.2018.6682

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  14 in total

1.  Identification of a compound heterozygous mutation of ABCC2 in a patient with hyperbilirubinemia.

Authors:  Rong Xiang; Jing-Jing Li; Liang-Liang Fan; Jie-Yuan Jin; Kun Xia; Fang Wang
Journal:  Mol Med Rep       Date:  2017-07-05       Impact factor: 2.952

2.  Dubin-Johnson syndrome in Israel. I. Clinical, laboratory, and genetic aspects of 101 cases.

Authors:  M Shani; U Seligsohn; E Gilon; C Sheba; A Adam
Journal:  Q J Med       Date:  1970-10

Review 3.  The molecular basis of jaundice: An old symptom revisited.

Authors:  Silvia Gazzin; Flora Masutti; Libor Vitek; Claudio Tiribelli
Journal:  Liver Int       Date:  2017-01-11       Impact factor: 5.828

4.  Effects of ABCB1, ABCC2, UGT2B7 and HNF4α genetic polymorphisms on oxcarbazepine concentrations and therapeutic efficacy in patients with epilepsy.

Authors:  Chunhong Shen; Bijun Zhang; Zhirong Liu; Yelei Tang; Yinxi Zhang; Shan Wang; Yi Guo; Yao Ding; Shuang Wang; Meiping Ding
Journal:  Seizure       Date:  2017-08-01       Impact factor: 3.184

5.  A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2).

Authors:  Verena Keitel; Anne T Nies; Manuela Brom; Johanna Hummel-Eisenbeiss; Herbert Spring; Dietrich Keppler
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-10-02       Impact factor: 4.052

6.  Mutation and functional analysis of ABCC2/multidrug resistance protein 2 in a Japanese patient with Dubin-Johnson syndrome.

Authors:  Takeshi Uchiumi; Hiroyuki Tanamachi; Kajiyo Kuchiwaki; Mitsuharu Kajita; Shinya Matsumoto; Mikako Yagi; Tomotake Kanki; Dongchon Kang
Journal:  Hepatol Res       Date:  2012-10-10       Impact factor: 4.288

7.  Identification of a novel 2026G-->C mutation of the MRP2 gene in a Japanese patient with Dubin-Johnson syndrome.

Authors:  Shinya Wakusawa; Ikuo Machida; Satoshi Suzuki; Hisao Hayashi; Motoyoshi Yano; Kentaro Yoshioka
Journal:  J Hum Genet       Date:  2003-07-22       Impact factor: 3.172

8.  Trafficking and functional defects by mutations of the ATP-binding domains in MRP2 in patients with Dubin-Johnson syndrome.

Authors:  Kenkichi Hashimoto; Takeshi Uchiumi; Toshikazu Konno; Takuya Ebihara; Takanori Nakamura; Morimasa Wada; Shotaro Sakisaka; Fumio Maniwa; Teruo Amachi; Kazumitsu Ueda; Michihiko Kuwano
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

Review 9.  Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences.

Authors:  Serge Erlinger; Irwin M Arias; Daniel Dhumeaux
Journal:  Gastroenterology       Date:  2014-04-01       Impact factor: 22.682

10.  Intravenous cholecystography and metabolism of meglumine iodipamide (Biligrafin) in Dubin-Johnson syndrome.

Authors:  M Morita; T Kihara
Journal:  Radiology       Date:  1971-04       Impact factor: 11.105

View more
  8 in total

1.  Concurrence of novel mutations causing Gilbert's and Dubin-Johnson syndrome with poor clinical outcomes in a Han Chinese family.

Authors:  Tai-Cheng Zhou; Xiao Li; Hui Li; Feng-Wei Liu; Si-Hang Zhang; Jing-Hua Fan; Wen-Xiu Yang; Ya-Li Yang; Liang Zhang; Jia Wei
Journal:  J Hum Genet       Date:  2022-10-24       Impact factor: 3.755

Review 2.  ABC transporter superfamily. An updated overview, relevance in cancer multidrug resistance and perspectives with personalized medicine.

Authors:  Pérez-De Marcos Juan-Carlos; Pérez-Pineda Perla-Lidia; Méndez-Morales Stephanie-Talia; Arellano-Mendoza Mónica-Griselda; Torres-Espíndola Luz-María
Journal:  Mol Biol Rep       Date:  2021-02-22       Impact factor: 2.316

3.  Neonatal Dubin-Johnson syndrome: biochemical parameters, characteristics, and genetic variants study.

Authors:  Haiyan Fu; Ruiqin Zhao; Xiaoyun Jia; Xiaolei Li; Guigui Li; Chunlan Yin
Journal:  Pediatr Res       Date:  2021-05-28       Impact factor: 3.953

4.  Clinical characteristics and ABCC2 genotype in Dubin-Johnson syndrome: A case report and review of the literature.

Authors:  Huan Wu; Xue-Ke Zhao; Juan-Juan Zhu
Journal:  World J Clin Cases       Date:  2021-02-06       Impact factor: 1.337

Review 5.  Will the Use of Pharmacogenetics Improve Treatment Efficiency in COVID-19?

Authors:  Beata Franczyk; Jacek Rysz; Jarosław Miłoński; Tomasz Konecki; Magdalena Rysz-Górzyńska; Anna Gluba-Brzózka
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-13

6.  A recurrent ABCC2 p.G693R mutation resulting in loss of function of MRP2 and hyperbilirubinemia in Dubin-Johnson syndrome in China.

Authors:  Lina Wu; Yanmeng Li; Yi Song; Donghu Zhou; Siyu Jia; Anjian Xu; Wei Zhang; Hong You; Jidong Jia; Jian Huang; Xiaojuan Ou
Journal:  Orphanet J Rare Dis       Date:  2020-03-18       Impact factor: 4.123

Review 7.  Pharmacogenetics Approach for the Improvement of COVID-19 Treatment.

Authors:  Ingrid Fricke-Galindo; Ramcés Falfán-Valencia
Journal:  Viruses       Date:  2021-03-05       Impact factor: 5.048

8.  Downregulated let-7d positively stimulates rectum adenocarcinoma cell malignant biological behaviors by upregulating ATP binding cassette subfamily C member 2.

Authors:  Zhen-Ji Liu; Yuan-Yuan Ma; Tong-Ming Liu; Jian-Xin Wang; Li Zhang; Lei Jin; Miao Yu; Hua-Long Yu
Journal:  Transl Cancer Res       Date:  2019-08       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.